Join a team that's redefining commercial content for executive stakeholders. Lead cross-functional collaboration to transform complex narratives into decision-ready materials, enhancing strategic engagement and communication at senior levels.

Join a team that's redefining rare disease strategy by leading long-range planning and prioritization efforts. Collaborate closely with top executives to drive clear, actionable insights that enhance decision-making and corporate strategy.

Lead the charge in driving Infigratinib's launch by engaging healthcare providers and families, leveraging your clinical expertise and strategic insight within the skeletal dysplasia community to exceed business goals and improve patient outcomes.

Bring your expertise to a pivotal role enhancing community engagement and provider collaboration. Drive the launch of innovative therapies for skeletal dysplasia while achieving sales objectives and cultivating key partnerships across multi-disciplinary teams.

Lead the charge in the launch of a groundbreaking therapy for achondroplasia. Drive impactful strategies for community engagement, establish strong HCP partnerships, and ensure compliance and success in the skeletal dysplasia landscape.